COVID-19 Registry Rhineland-Palatinate (Germany)
Study Details
Study Description
Brief Summary
Documentation of all patients undergoing inpatient treatment for SARS-CoV-2 infection with regard to clinical status at admission, medical history, inpatient treatment and course of disease. The aim is to create a risk stratification of the infection on the basis of clinical data as well as therapy and disease progression of the patients. This may also contribute to a better planning of resources.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| In-patients with SARS-CoV-2 infection In-patients fulfilling the following criteria: SARS-CoV-2 infection In-patient treatment Written informed consent for participation in observational study No explicit medical exclusion criteria are stated to avoid selection bias. |
Other: Prospective oberservational registry
Non interventional study.
|
Outcome Measures
Primary Outcome Measures
- Chest x-ray [throughout study completion, in average 1.5 years]
presence of infiltrates
- Chest CT [throughout study completion, in average 1.5 years]
presence of infiltrates
- Supportive care - ICU [throughout study completion, in average 1.5 years]
number of patients with ICU treatment required
- Supportive care - oxygen therapy [throughout study completion, in average 1.5 years]
number of patients with oxygen therapy required
- Supportive care - ventilation [throughout study completion, in average 1.5 years]
number of patients with ventilation required
- Medication [throughout study completion, in average 1.5 years]
number of patients with medication changes
- Therapeutic strategies [throughout study completion, in average 1.5 years]
number of patients with ECMO required
- Lab parameters [throughout study completion, in average 1.5 years]
number of patients with significant changes in lab parameters
- Intra-hospital complications [throughout study completion, in average 1.5 years]
number of patients with complications during hospital stay
- Vital status at discharge [throughout study completion, in average 1.5 years]
vital status at discharge: alive, dead
Eligibility Criteria
Criteria
Inclusion Criteria:
- In-patients fulfilling the following criteria:
SARS-CoV-2 infection In-patient treatment Written informed consent for participation in observational study
Exclusion Criteria:
- No explicit medical exclusion criteria are stated to avoid selection bias.
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Klinikum der Stadt Ludwigshafen am Rhein GmbH, Klinik für Herzchirurgie | Ludwigshafen | RLP | Germany | 67063 |
Sponsors and Collaborators
- IHF GmbH - Institut für Herzinfarktforschung
- Ministerium für Soziales, Arbeit, Gesundheit und Demografie des Landes Rheinland-Pfalz
Investigators
- Study Chair: Anselm Gitt, MD, Stiftung IHF and Klinikum der Stadt Ludwigshafen
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- COVID-19 Registry